Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens
- PMID: 4436788
- DOI: 10.1002/jps.2600631014
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens
Similar articles
-
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.Biochem Pharmacol. 1974 Jan 1;23(1):115-29. doi: 10.1016/0006-2952(74)90318-9. Biochem Pharmacol. 1974. PMID: 4811053 No abstract available.
-
Gas chromatographic method for the determination of plasma isophosphamide (NSC-109724).Cancer Chemother Rep. 1972 Dec;56(6):721-3. Cancer Chemother Rep. 1972. PMID: 4660630 No abstract available.
-
Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.Cancer Res. 1972 Nov;32(11):2519-23. Cancer Res. 1972. PMID: 5082597 No abstract available.
-
In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.Cancer Chemother Rep. 1972 Oct;56(5):603-10. Cancer Chemother Rep. 1972. PMID: 4405717 No abstract available.
-
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography.Cancer Treat Rep. 1976 Apr;60(4):493-500. Cancer Treat Rep. 1976. PMID: 1277226
Cited by
-
Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma.Cancer Chemother Pharmacol. 1983;11(3):196-9. doi: 10.1007/BF00254204. Cancer Chemother Pharmacol. 1983. PMID: 6640827
-
Detection of contamination with antineoplastic agents in a hospital pharmacy department.Pharm Weekbl Sci. 1992 Feb 21;14(1):16-22. doi: 10.1007/BF01989220. Pharm Weekbl Sci. 1992. PMID: 1553250
-
Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide.Int Arch Occup Environ Health. 1986;58(2):151-5. doi: 10.1007/BF00380766. Int Arch Occup Environ Health. 1986. PMID: 3744569
-
Decreased plasma half-life of cyclophosphamide during repeated high-dose administration.Cancer Chemother Pharmacol. 1983;10(3):192-3. doi: 10.1007/BF00255760. Cancer Chemother Pharmacol. 1983. PMID: 6861264
-
Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapy.Br J Clin Pharmacol. 1980 Sep;10(3):281-5. doi: 10.1111/j.1365-2125.1980.tb01756.x. Br J Clin Pharmacol. 1980. PMID: 7437246 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources